Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

Autor:	Ribaudo, Heather J., Liu, Huan, Schwab, Matthias, Schaeffeler, Elke, Eichelbaum, Michel, Motsinger-Reif, Alison A., Ritchie, Marylyn D., Zanger, Ulrich M., Acosta, Edward P., Morse, Gene D., Gulick, Roy M., Robbins, Gregory K., Clifford, David, Haas, David W.
Zdroj:	The Journal of Infectious Diseases, 2010 Sep 01. 202(5), 717-722.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/25706980 Zobrazit plný text záznamu